PedAM
Pediatric Disease Annotations & Medicines
| Disease | c syndrome |
| Phenotype | C0032460|polycystic ovary |
| Sentences | 18 |
| PubMedID- 26488852 | Targets to treat metabolic syndrome in polycystic ovary syndrome. |
| PubMedID- 22985575 | Objective: to study the characteristics of the metabolic syndrome (ms) in patients with polycystic ovary syndrome (pcos). |
| PubMedID- 22888988 | Prevalence of metabolic syndrome in women with polycystic ovary syndrome. |
| PubMedID- 22870011 | Objective: the aim of the present study was to evaluate the prevalence of metabolic syndrome in women with polycystic ovary syndrome (pcos). |
| PubMedID- 20396356 | Objective: to study characteristics of the metabolic syndrome (ms) in patients with polycystic ovary syndrome (pcos) according to 2004 diagnostic criteria by the chinese diabetes society (cds). |
| PubMedID- 21450287 | Objective: to determine prevalence of metabolic syndrome in adolescents with polycystic ovary syndrome (pcos) and derive features suggestive of propensity for development of metabolic syndrome. |
| PubMedID- 23283052 | Objective: the aim of this study was to assess the association between premicroalbuminuria and metabolic syndrome in women with polycystic ovary syndrome (pcos). |
| PubMedID- 24592034 | Prediction of metabolic syndrome in women with polycystic ovary syndrome. |
| PubMedID- 23426706 | Lipid accumulation product is related to metabolic syndrome in women with polycystic ovary syndrome. |
| PubMedID- 20540665 | Prevalence of metabolic syndrome in women with polycystic ovary syndrome, using two proposed definitions. |
| PubMedID- 20807165 | Metabolic syndrome in adolescents with polycystic ovary syndrome. |
| PubMedID- 21277789 | Women of reproductive age are not spared from the complications of metabolic syndrome, which overlaps with obesity and polycystic ovary syndrome (pcos), both of which are linked to infertility and poor reproductive outcome. |
| PubMedID- 21251033 | Articles were summarised and grouped according to different sections defining interactions of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease as well as risk factors, pathogenic pathways and treatment options. |
| PubMedID- 20199774 | Insulin resistance, dyslipidemia, and metabolic syndrome in women with polycystic ovary syndrome. |
| PubMedID- 20925278 | [the prevalence of metabolic syndrome in women with polycystic ovary syndrome]. |
| PubMedID- 23656383 | Cigarette smoking, nicotine levels and increased risk for metabolic syndrome in women with polycystic ovary syndrome. |
| PubMedID- 23885694 | Age- and body mass index-related differences in the prevalence of metabolic syndrome in women with polycystic ovary syndrome. |
| PubMedID- 23028012 | In this context, polycystic ovary syndrome, associated with the metabolic syndrome and high testosterone levels, is the most common cause of irregular periods in young women and could underlie an association between asthma and sex-hormone levels (3). |
Page: 1